GA
ENZY

Gagnon Advisors’s Enzymotec Ltd ENZY Stock Holding History

Gagnon Advisors’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-130,313
Closed -$2.67M – 29
2017
Q1 		$2.67M Hold
130,313
– – 2.44% 19
2016
Q4 		$2.4M Sell
130,313
-59,863
-31% -$394K 1.99% 21
2016
Q3 		$1.33M Hold
190,176
– – 1.05% 25
2016
Q2 		$1.59M Buy
+190,176
New +$1.58M 1.34% 22

Other funds holding ENZY

PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $30.9B AUM 29.72% 1-Year Est. Return

Gagnon Advisors's ENZY Position: Q2 2017 in Review

Gagnon Advisors sold out of Enzymotec Ltd (ENZY) in Q2 2017, closing a stake of 130,313 shares — an estimated $2.67M sold.

Gagnon Advisors first reported a position in ENZY in Q2 2016 and held it in 4 quarters. The position peaked at $2.67M in Q1 2017. 21 funds tracked by Wall St. Rank hold ENZY as of Q2 2017.

  • Gagnon Advisors reported no remaining Enzymotec Ltd position as of Q2 2017 after selling out during the quarter.
  • Gagnon Advisors sold 130,313 Enzymotec Ltd shares in Q2 2017, an estimated $2.67M.
  • Gagnon Advisors first reported a position in Enzymotec Ltd in Q2 2016 and held it in 4 quarters.
  • Gagnon Advisors's Enzymotec Ltd position peaked at $2.67M in Q1 2017.
  • 21 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q2 2017.

Based on Gagnon Advisors's 13F filing for Q2 2017, filed 20 Jul 2017.